https://ntp.niehs.nih.gov/go/3883

TDMS Study 05069-06 Pathology Tables

                              INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)
                                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE
NTP Experiment-Test: 05069-06                                                                                     Report: PEIRPT05
Study Type: INIT/PROMOT                                                                                           Date: 10/19/93
Route: DERMAL,SOLUTION                                                                                            Time: 18:16:59
       Facility:  TSI Mason Research
       Chemical CAS #:  147-47-7
       Lock Date:  09/17/93
       Cage Range:  All
       Reasons For Removal:    All
       Removal Date Range:     All
       Treatment Groups:       Include 011    ACETONE/ACETONE
                               Include 004    ACET/TMQ5 MG/KG
                               Include 005    ACET/TMQ10 MG/KG
                               Include 006    ACET/TMQ25 MG/KG
a  Number of animals examined microscopically at site and number of animals with lesion
                                                             Page   1
NTP Experiment-Test: 05069-06  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05  
Study Type: INIT/PROMOT                            1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 10/19/93    
Route: DERMAL,SOLUTION                                                                                            Time: 18:16:59    
____________________________________________________________________________________________________________________________________
         SENCAR MICE FEMALE                  ACETONE/        ACET/TMQ     ACET/TMQ     ACET/TMQ                                     
                                             ACETONE         5 MG/KG      10 MG/KG     25 MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially in Study                    30              30           30           30                                        
  Early Deaths                                                                                                                      
    Natural Death                                                1            1            2                                        
    Moribund Sacrifice                           2                                         1                                        
  Survivors                                                                                                                         
    Terminal Sacrifice                          27              29           29           27                                        
    Natural Death                                1                                                                                  
  Animals Examined Microscopically              30              30           30           30                                        
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Liver                                        (30)            (30)         (30)         (30)                                      
      Hepatocellular Adenoma                     1 (3%)                       1 (3%)                                                
      Sarcoma Stromal, Metastatic, Uterus                                                  1 (3%)                                   
   Stomach, Forestomach                                         (1)                                                                 
      Squamous Cell Papilloma                                    1 (100%)                                                           
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Ovary                                        (1)             (1)                       (1)                                       
      Sarcoma Stromal, Metastatic, Uterus                                                  1 (100%)                                 
   Uterus                                                                                 (1)                                       
      Sarcoma Stromal                                                                      1 (100%)                                 
____________________________________________________________________________________________________________________________________
                                                             Page   2                                                               
NTP Experiment-Test: 05069-06  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05  
Study Type: INIT/PROMOT                            1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 10/19/93    
Route: DERMAL,SOLUTION                                                                                            Time: 18:16:59    
____________________________________________________________________________________________________________________________________
         SENCAR MICE FEMALE                  ACETONE/        ACET/TMQ     ACET/TMQ     ACET/TMQ                                     
                                             ACETONE         5 MG/KG      10 MG/KG     25 MG/KG                                     
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   Kidney                                       (1)             (1)                       (1)                                       
      Sarcoma Stromal, Metastatic, Uterus                                                  1 (100%)                                 
                                                             Page   3                                                               
NTP Experiment-Test: 05069-06  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05  
Study Type: INIT/PROMOT                            1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 10/19/93    
Route: DERMAL,SOLUTION                                                                                            Time: 18:16:59    
____________________________________________________________________________________________________________________________________
         SENCAR MICE FEMALE                   ACETONE/      ACET/TMQ     ACET/TMQ     ACET/TMQ                                      
                                              ACETONE       5 MG/KG      10 MG/KG     25 MG/KG                                      
____________________________________________________________________________________________________________________________________
TUMOR SUMMARY                                                                                                                       
   Total Animals with Primary Neoplasms (b)     1                1           1           1                                          
     Total Primary Neoplasms                    1                1           1           1                                          
   Total Animals with Benign Neoplasms          1                1           1                                                      
     Total Benign Neoplasms                     1                1           1                                                      
   Total Animals with Malignant Neoplasms                                                1                                          
     Total Malignant Neoplasms                                                           1                                          
   Total Animals with Metastatic Neoplasms                                               1                                          
     Total Metastatic Neoplasm                                                           3                                          
   Total Animals with Malignant Neoplasms                                                                                           
   Uncertain Primary Site                                                                                                           
   Total Animals with Neoplasms Uncertain-                                                                                          
   Benign or Malignant                                                                                                              
     Total Uncertain Neoplasms                                                                                                      
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Primary tumors: all tumors except metastatic tumors                                                                              
                                                             Page   4                                                               
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------